Yan-hua Wang
Adachi, 1238558, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Tyrosine kinase inhibitors modulate the expression of peroxiredoxins 1 and 2 in chronic myeloid leukemia cells.
Journal: Leukemia research reports
Published: February 04, 2025
Elotuzumab Enhances CD16-Independent NK Cell-Mediated Cytotoxicity against Myeloma Cells by Upregulating Several NK Cell-Enhancing Genes.
Journal: Journal of immunology research
Published: November 24, 2023
High PRAME expression is associated with poor survival and early disease progression in myelodysplastic syndromes with a low bone marrow blast percentage.
Journal: Leukemia & lymphoma
Published: May 20, 2021
Reduced PLCG1 expression is associated with inferior survival for myelodysplastic syndromes.
Journal: Cancer medicine
Published: April 11, 2019
Expression analysis of genes located within the common deleted region of del(20q) in patients with myelodysplastic syndromes.
Journal: Leukemia research
Published: March 15, 2019
Knockdown of the Wnt receptor Frizzled-1 (FZD1) reduces MDR1/P-glycoprotein expression in multidrug resistant leukemic cells and inhibits leukemic cell proliferation.
Journal: Leukemia research
Published: August 24, 2017
Histone deacetylase inhibitor panobinostat induces calcineurin degradation in multiple myeloma.
Journal: JCI insight
Published: October 05, 2016
Aberrant methylation and decreased expression of the RIZ1 gene are frequent in adult acute lymphoblastic leukemia of T-cell phenotype.
Journal: Leukemia & lymphoma
Published: February 04, 2012
Overexpression of lung resistance-related protein and P-glycoprotein and response to induction chemotherapy in acute myelogenous leukemia.
Journal: Hematology reports
Published: January 18, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026